COVID-19 RESPONSE - We are committed to supporting our scientific community during this pandemic. Learn more 


Novel assay methods for cancer patient derived organoids

This poster presents results from semi-automated PDO assays using a Pu•MA System coupled with high-content imaging.

  • Capabilities of a novel automated organoid assay system that performs complex protocols with 3D cell models in an incubator environment.
  • Patient-derived organoids derived from primary tumors were assayed for compound response using high resolution confocal imaging of cell surface markers and viability stains for Live/Dead.
  • The ability to analyze spheroids and organoids in situ in order to capture toxicity information and perform functional assays shows great promise for disease modeling.

Register to download your scientific poster today